Reduced severity of ischemic stroke and improvement of mitochondrial function after dietary treatment with the anaplerotic substance triheptanoin

Neuroscience

Volumn 300, Issue , 2015, Pages 201-209

  Schwarzkopf, T M ^a   Koch, K ^a   Klein, J ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

Anaplerosis; Brain ischemia; Heptanoic acid; Microdialysis; Middle cerebral artery occlusion; Mitochondrial respiration

Indexed keywords

ADENOSINE TRIPHOSPHATE; FATTY ACID; GLUCOSE; GLUTAMIC ACID; SOYBEAN OIL; TRIHEPTANOIN; MATRIX METALLOPROTEINASE; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR CHANGE; BLOOD LEVEL; BODY WEIGHT; BRAIN FUNCTION; BRAIN ISCHEMIA; CELL FUNCTION; CELL LEVEL; CHIMNEY TEST; CONTROLLED STUDY; CORNER TEST; DIETARY INTAKE; DISEASE SEVERITY; EXPERIMENTAL TEST; FEMALE; FUNCTIONAL ASSESSMENT; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRIAL RESPIRATION; MITOCHONDRION; MOLECULAR DYNAMICS; MOUSE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; ROTAROD TEST; TREATMENT RESPONSE; ANIMAL; BRAIN; CEREBRAL ARTERY DISEASE; CEREBROVASCULAR ACCIDENT; DIET THERAPY; DISEASE MODEL; ELECTRON TRANSPORT; METABOLISM; MOTOR ACTIVITY; OXYGEN CONSUMPTION; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SEVERITY OF ILLNESS INDEX;

ADENOSINE TRIPHOSPHATE; ANIMALS; BODY WEIGHT; BRAIN; BRAIN ISCHEMIA; DISEASE MODELS, ANIMAL; ELECTRON TRANSPORT; FATTY ACIDS; FEMALE; GLUCOSE; GLUTAMIC ACID; INFARCTION, MIDDLE CEREBRAL ARTERY; MATRIX METALLOPROTEINASES; MICE; MITOCHONDRIA; MOTOR ACTIVITY; OXYGEN CONSUMPTION; SEVERITY OF ILLNESS INDEX; STROKE; TRIGLYCERIDES;

EID: 84930637918     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2015.05.014     Document Type: Article

References (34)

1. Borges K., Sonnewald U. Triheptanoin - a medium chain triglyceride with odd chain fatty acids: a new anaplerotic anticonvulsant treatment?. Epilepsy Res 2012, 100:239-244.
2. Bouet V., Freret T., Toutain J., Divoux D., Boulouard M., Schumann-Bard P. Sensorimotor and cognitive deficits after transient middle cerebral artery occlusion in the mouse. Exp Neurol 2007, 203:555-567.
3. Brunengraber H., Roe C.R. Anaplerotic molecules: current and future. J Inherit Metab Dis 2006, 29:327-331.
4. Canevari L., Kuroda S., Bates T.E., Clark J.B., Siesjö B.K. Activity of mitochondrial respiratory chain enzymes after transient focal ischemia in the rat. J Cereb Blood Flow Metab 1997, 17:1166-1169.
5. Danbolt N.C. Glutamate uptake. Prog Neurobiol 2001, 65:1-105.
6. Dirnagl U., Iadecola C., Moskowitz M.A. Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci 1999, 22:391-397.
7. Eckert S.H., Eckmann J., Renner K., Eckert G.P., Leuner K., Müller W.E. Dimebon ameliorates amyloid-beta induced impairments of mitochondrial form and function. J Alzheimers Dis 2012, 31:21-32.
8. Folch J., Lees M., Sloane-Stanley G.H. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 1957, 226:497-509.
9. Franklin K.B.J., Paxinos G. A stereotaxic atlas of the mouse brain 1997, Academic Press, San Diego.
10. Gasior M., Rogawski M.A., Hartmann A.L. Neuroprotective and disease-modifying effects of the ketogenic diet. Behav Pharmacol 2006, 17:431-439.
11. Gibson C.L., Bath P.M.W., Murphy S.P. G-CSF reduces infarct volume and improves functional outcome after transient focal cerebral ischemia in mice. J Cereb Blood Flow Metab 2005, 25:431-439.
12. Gu L., Zhang G.F., Kombu R.S., Allen F., Kutz G., Brewer W.U., Roe C.R., Brunengraber H. Parenteral and enteral metabolism of anaplerotic triheptanoin in normal rats. II. Effects on lipolysis, glucose production, and liver acyl-CoA profile. Am J Physiol Endocrinol Metab 2010, 298:362-371.
13. Haberg A.K., Qu H., Sonnewald U. Acute changes in intermediary metabolism in cerebellum and contralateral hemisphere following middle cerebral artery occlusion in rat. J Neurochem 2009, 109(Suppl. 1):174-181.
14. Hand S.C., Lemieux H., Gnaiger E. Basic protocol with isolated mitochondria: LEAK, OXPHOS, ETS, ROX. Mito Phys Net 2010, 12(11):1-5.
15. Heinecke H. A comparison of two variants of the chimney behaviour test in mice. Z Versuchstierkd 1987, 29:145-148.
16. Janssens D., Delaive E., Remacle J., Michiels C. Protection by bilobalide of the ischaemia-induced alterations of the mitochondrial respiratory activity. Fundam Clin Pharmacol 2000, 14:193-201.
17. Jones B.J., Roberts D.J. The quantitative measurement of motor incoordination in naive mice using an accelerating rotarod. J Pharm Pharmacol 1968, 20:302-304.
18. Kim T.H., Borges K., Petrou S., Reid C.A. Triheptanoin reduces seizure susceptibility in a syndrome-specific mouse model of generalized epilepsy. Epilepsy Res 2013, 103:101-105.
19. Kinman R.P., Kasumov T., Jobbins K.A., Thomas K.R., Adams J.E., Brunengraber L.N., Kutz G., Brewer W.U., Roe C.R., Brunengraber H. Parenteral and enteral metabolism of anaplerotic triheptanoin in normal rats. Am J Physiol Endocrinol Metab 2006, 291:860-866.
20. Kombu RS, Brunengraber H, Puchowicz MA (2011) Analysis of the citric acid cycle intermediates using gas chromatography-mass spectrometry. In: Metabolic profiling (Metz TO, ed.), Methods in molecular biology, Vol. 708, pp. 147-157.
21. Lassnig B., Stadlmann S., Rieger G., Haffner B., Lemieux H., Gnaiger E. Selected media and chemicals for respirometry with mitochondria and permeabilized cells. Mito Phys Net 2011, 03(02):1-9.
22. Lipton P. Ischemic cell death in brain neurons. Physiol Rev 1999, 79:1431-1568.
23. Lopez A.D., Mathers C.D., Ezzati M., Jamison D.T., Murray C.J. Global and regional burden of disease and risk factors: systematic analysis of population health data. Lancet 2006, 367:1747-1757.
24. Marin-Valencia I., Good L.B., Ma Q., Malloy C.R., Pascual J.M. Heptanoate as a neural fuel: energetic and neurotransmitter precursors in normal and glucose transporter I-deficient (G1D) brain. J Cereb Blood Flow Metab 2013, 33:175-182.
25. Mochel F., DeLonlay P., Touati G., Brunengraber H., Kinman R.P., Rabier D., Roe C.R., Saudubray J.M. Pyruvate carboxylase deficiency: clinical and biochemical response to anaplerotic diet therapy. Mol Genet Metab 2005, 84:305-312.
26. Mochel F., Duteil S., Marelli C., Jauffret C., Barles A., Holm J., Sweetman L., Benoist J.F., Rabier D., Carlier P.G., Durr A. Dietary anaplerotic therapy improves peripheral tissue energy metabolism in patients with Huntington's disease. Eur J Hum Genet 2010, 18:1057-1060.
27. Roe C.R., Bottiglieri T., Wallace M., Arning E., Martin A. Adult Polyglucosan Body Disease (APBD): anaplerotic diet therapy (triheptanoin) and demonstration of defective methylation pathways. Mol Genet Metab 2010, 101:246-452.
28. Schwarzkopf T., Koch K., Klein J. Neurodegeneration after transient brain ischemia in aged mice: beneficial effects of bilobalide. Brain Res 2013, 1529:178-187.
29. Spiekerkoetter U., Bastin J., Gillingham M., Morris A., Wijburg F., Wicken B. Current issues regarding treatment of mitochondrial fatty acid oxidation disorders. J Inherit Metab Dis 2010, 33. 555-461.
30. Stoll L., Müller W.E. In vitro down-regulation predicts agonist efficacy at central muscarinic cholinergic receptors. Biochem Pharmacol 1991, 41:1963-1966.
31. Strong K., Mathers C., Bonita R. Preventing stroke: saving lives around the world. Lancet Neurol 2007, 6:182-187.
32. Thomas N.K., Willis S., Sweetman L., Borges K. Triheptanoin in acute mouse seizure models. Epilepsy Res 2012, 99:312-317.
33. Willis S., Stoll J., Sweetman L., Borges K. Anticonvulsant effects of a triheptanoin diet in two mouse chronic seizure models. Neurobiol Dis 2010, 40:565-572.
34. Zhang L., Schallert T., Zhang Z.G., Jiang Q., Arniego P., Li Q., Lu M., Chopp M. A test for detecting long-term sensorimotor dysfunction in the mouse after focal cerebral ischemia. J Neurosci Methods 2002, 117:207-214.